UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
PBM holding history
Psyence Biomedical Ltd. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PBM overviewAll 13F holders of PBMFull Q2 2026 holdings
- Shares (Q2 2026)
- 60
- Value
- $184
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 60 | $184 | <0.1% | +60 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −1,007−100.0% | Sold out | Holders |
| Q4 2025 | 1,007 | $758 | <0.1% | +1,007 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −1,956−100.0% | Sold out | Holders |
| Q2 2025 | 1,956 | $10.4K | <0.1% | −31,603−94.2% | Reduced | Holders |
| Q1 2025 | 33,559 | $20.1K | <0.1% | +20,847+164.0% | Added | Holders |
| Q4 2024 | 12,712 | $26.8K | <0.1% | −2,318−15.4% | Reduced | Holders |
| Q3 2024 | 15,030 | $1.50K | <0.1% | −7,855−34.3% | Reduced | Holders |
| Q2 2024 | 22,885 | $6.87K | <0.1% | +20,521+868.1% | Added | Holders |
| Q1 2024 | 2,364 | $2.69K | <0.1% | +2,364 | New | Holders |